Drug General Information |
Drug ID |
D0W9NH
|
Former ID |
DCL001122
|
Drug Name |
Tacedinaline
|
Synonyms |
Acetyldinaline; Tacedinalina; Goe 5549; PD 123654; Ci-994; Goe-5549; PD-123654; Tacedinalina [INN-Spanish]; Tacedinaline [USAN:INN]; C.I. 994; Tacedinaline (USAN/INN); 4-(Acetylamino)-N-(2-aminophenyl)benzamide; 4-acetamido-N-(2-aminophenyl)benzamide; 4-acetamido-n-(2-aminophenyl)benzamid; 4-acetylamino-N-(2'-aminophenyl)benzamide
|
Drug Type |
Small molecular drug
|
Company |
National Cancer Institute (NCI)
|
Structure |
|
Download
2D MOL
3D MOL
|
Formula |
C15H15N3O2
|
InChI |
InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)
|
InChIKey |
VAZAPHZUAVEOMC-UHFFFAOYSA-N
|
PubChem Compound ID |
|
PubChem Substance ID |
6897908, 8151773, 12014151, 14848338, 29221901, 46519444, 47207646, 49875144, 57321429, 76461531, 87226490, 93619303, 103137194, 103537395, 104301487, 117537664, 118843066, 121363787, 123391000, 124360040, 125338021, 126671706, 129449051, 134345068, 134964212, 135074618, 135698188, 136367989, 137022499, 137237670, 141654160, 144115829, 152029810, 152159635, 152186807, 160871335, 162012039, 162205195, 162248589, 163121968, 163621122, 163686462, 164193980, 164224003, 164824268, 172095414, 172911911, 175608160, 179148456, 184538256
|
Target and Pathway |
References |